Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Fk 1160
2. Nta-194
3. Solantal
4. Tiaramide
5. Tiaramide Monohydrochloride
1. 35941-71-0
2. 5-chloro-3-(2-(4-(2-hydroxyethyl)piperazin-1-yl)-2-oxoethyl)benzo[d]thiazol-2(3h)-one Hydrochloride
3. Tiaramide Hcl
4. Solantal
5. Nta-194
6. Tiaramide Hydrochloride-r
7. Usv 2592 Hcl
8. Fk 1160
9. Nsc-289337
10. Fk-1160
11. 4-[(5-chloro-2-oxo-2h-benzothiazol-3-yl)acetyl]piperazine-1-ethanol Monohydrochloride
12. Ity1616x9t
13. Rhc-2592
14. 35941-71-0 (hcl)
15. 4-((5-chloro-2-oxo-3-benzothiazolinyl)acetyl)-1-piperazineethanol Monohydrochloride
16. Thiaramide
17. Fk 1160; Nsc 289337; Nta 194; Rhc 2592
18. Ventaval Tabletten
19. 1-piperazineethanol, 4-((5-chloro-2-oxo-3(2h)-benzothiazolyl)acetyl)-, Monohydrochloride
20. Thiaramide [german]
21. Nsc289337
22. Unii-ity1616x9t
23. 4-((5-chloro-2-oxo-2h-benzothiazol-3-yl)acetyl)piperazine-1-ethanol Monohydrochloride
24. Nta 194
25. Solantal (tn)
26. Einecs 252-802-7
27. Tiaramide Hydrochloride [usan:jan]
28. Nta-194tiaramide
29. Nsc 289337
30. Dsstox_cid_28683
31. Dsstox_rid_82953
32. Nta-194 Hcl
33. Dsstox_gsid_48757
34. Schembl181916
35. Chembl538059
36. Dtxsid6048757
37. Chebi:32222
38. Tiaramide Hydrochloride [mi]
39. Tox21_113221
40. Bdbm50222213
41. Fk1160
42. Mfcd01702832
43. Tiaramide Hydrochloride [jan]
44. 1-piperazineethanol, Monohydrochloride
45. Tiaramide Hydrochloride [usan]
46. Akos024464353
47. Tiaramide Hydrochloride (jp17/usan)
48. Tiaramide Hydrochloride [mart.]
49. 2-benzothiazolinone, 5-chloro-3-(4-(2-hydroxyethyl)-1-piperazinyl)carbonylmethyl-, Hcl
50. 4-((5-chloro-2-oxo-3(2h)-benzothiazolyl)acetyl)-1-piperazineethanol Hydrochloride
51. 5-chloro-3-(4-(2-hydroxyethyl)-1-piperazinyl)carbonylmethyl-2-benzothiazolinone Hydrochloride
52. Tiaramide Hydrochloride [who-dd]
53. 5-chloro-3-[2-[4-(2-hydroxyethyl)piperazin-1-yl]-2-oxoethyl]-1,3-benzothiazol-2-one;hydrochloride
54. As-74709
55. Cas-35941-71-0
56. T3176
57. D01341
58. D92667
59. A874495
60. Q27280902
61. 1-piperazineethanol, 4-((5-chloro-2-oxo-3(2h)-benzothiazolyl)acetyl)-, Hydrochloride
62. 4-[(5-chloro-2-oxo-2h-benzothiazol-3-yl)acetyl]piperazine-1-ethanolmonohydrochloride
63. 4-[(5-chloro-2-oxo-3-benzothiazolinyl)acetyl]-1-piperazineethanol Hydrochloride
64. 2(3h)-benzothiazolone, 5-chloro-3-(2-(4-(2-hydroxyethyl)-1-piperazinyl)-2-oxoethyl)-, Hydrochloride (1:1)
65. 5-chloro-3-(2-(4-(2-hydroxyethyl)piperazin-1-yl)-2-oxoethyl)benzo[d]thiazol-2(3h)-onehydrochloride
66. 5-chloro-3-[[4-(2-hydroxyethyl)piperazin-1-yl]carbonylmethyl]-2-benzothiazolinone Hydrochloride
67. 5-chloro-3-{2-[4-(2-hydroxyethyl)piperazin-1-yl]-2-oxoethyl}-2,3-dihydro-1,3-benzothiazol-2-one Hydrochloride
| Molecular Weight | 392.3 g/mol |
|---|---|
| Molecular Formula | C15H19Cl2N3O3S |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 391.0524180 g/mol |
| Monoisotopic Mass | 391.0524180 g/mol |
| Topological Polar Surface Area | 89.4 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 459 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
ABOUT THIS PAGE
55
PharmaCompass offers a list of Tiaramide Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tiaramide Hydrochloride manufacturer or Tiaramide Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tiaramide Hydrochloride manufacturer or Tiaramide Hydrochloride supplier.
PharmaCompass also assists you with knowing the Tiaramide Hydrochloride API Price utilized in the formulation of products. Tiaramide Hydrochloride API Price is not always fixed or binding as the Tiaramide Hydrochloride Price is obtained through a variety of data sources. The Tiaramide Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Solantal (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Solantal (TN), including repackagers and relabelers. The FDA regulates Solantal (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Solantal (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Solantal (TN) supplier is an individual or a company that provides Solantal (TN) active pharmaceutical ingredient (API) or Solantal (TN) finished formulations upon request. The Solantal (TN) suppliers may include Solantal (TN) API manufacturers, exporters, distributors and traders.
click here to find a list of Solantal (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Solantal (TN) DMF (Drug Master File) is a document detailing the whole manufacturing process of Solantal (TN) active pharmaceutical ingredient (API) in detail. Different forms of Solantal (TN) DMFs exist exist since differing nations have different regulations, such as Solantal (TN) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Solantal (TN) DMF submitted to regulatory agencies in the US is known as a USDMF. Solantal (TN) USDMF includes data on Solantal (TN)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Solantal (TN) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Solantal (TN) suppliers with USDMF on PharmaCompass.
Solantal (TN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Solantal (TN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Solantal (TN) GMP manufacturer or Solantal (TN) GMP API supplier for your needs.
A Solantal (TN) CoA (Certificate of Analysis) is a formal document that attests to Solantal (TN)'s compliance with Solantal (TN) specifications and serves as a tool for batch-level quality control.
Solantal (TN) CoA mostly includes findings from lab analyses of a specific batch. For each Solantal (TN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Solantal (TN) may be tested according to a variety of international standards, such as European Pharmacopoeia (Solantal (TN) EP), Solantal (TN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Solantal (TN) USP).
